Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (2018 - 2025)

Health Catalyst's Shares Outstanding history spans 8 years, with the latest figure at $72.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 12.63% year-over-year to $72.1 million; the TTM value through Dec 2025 reached $72.1 million, up 12.63%, while the annual FY2025 figure was $72.1 million, 12.63% up from the prior year.
  • Shares Outstanding reached $72.1 million in Q4 2025 per HCAT's latest filing, up from $70.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $72.1 million in Q4 2025 to a low of $44.3 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $58.3 million, with a median of $57.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: rose 22.78% in 2021, then rose 4.39% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $52.6 million in 2021, then increased by 5.02% to $55.3 million in 2022, then rose by 5.49% to $58.3 million in 2023, then rose by 9.86% to $64.0 million in 2024, then grew by 12.63% to $72.1 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Shares Outstanding are $72.1 million (Q4 2025), $70.7 million (Q3 2025), and $70.3 million (Q2 2025).